- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Cannabis Quality- Strategies & Solutions Summit
Steph and Jahan are both excited to have the opportunity to be speaking at an event like this which presents a great opportunity to communicate with state regulators and so many talented individuals working in medical cannabis.
Cannabis prohibition is almost over. A vast, once-underground cottage industry is professionalizing, and now looking at tens of billions in legal sales nationally.
However, until full federal legalization, much remains murky. State regulations are a Work-In-Progress, changing weekly. Yet the future Rules of the Road are being laid down. Regulators are writing guidelines for how grow, extraction, production and retail operations need to be run, and what testing procedures need to be met in order to maintain licenses. Contaminants are an immediate roadblock. Testing by independent labs becomes critical. The testing labs themselves need to operate by common standards, and be certified. In parallel, testing for potency – the relative percentages of dozens of active, synergistic cannabinoids -- goes to the very heart of the Medical Marijuana value proposition.
Attend the Cannabis Quality Strategies & Solutions Summit to stay on top of the most cutting-edge developments and network with: officials from multiple states, quality operations and testing experts, cannabinoid/biomedical research gurus, policy-makers, leading voices from the movement, and solution providers. This event will raise the discussion to a new level.
July 19, 2016 at 12pm - July 21, 2016
Millennium Biltmore Hotel, Los Angeles, CA
Erin Dolleris Hall · · 818-888-4445 x48